The Kirklin Clinic
Birmingham, Alabama, 35294, United States
NCT Number: NCT03122366
Toll-like receptors (TLRs) play a key role in the innate immune system. Toll-like receptor-4 (TLR4) in particular, appears to play a role in susceptibility to cancer. Of 44 identified SNPs (small nucleotide polymorphisms) in TLR4, the most common is an A-G substitution at nucleotide position +896, downstream of the cDNA start codon, a missense mutation which leads to an amino acid substitution Asp299Gly in the third exon of the TLR4 gene. Pre-clinical studies from our laboratory have shown an association of TLR4 with ultraviolet radiation induced skin cancer. Hence, in this study we will assess the pattern of TLR4 polymorphisms and susceptibility to skin cancer.
Looking for future studies?
Notify Me50 year–99 year
All sexes
Observational
Birmingham, Alabama, 35294, United States
Toll-like receptors (TLRs) play a key role in the innate immune system. Toll-like receptors generally, and TLR4 in particular, appear to play a role in cancer susceptibility as well as tumor immunosuppression and stromal invasion. Of 44 identified SNPs (small nucleotide polymorphisms) in TLR4, the most common is an A-G substitution at nucleotide position +896, downstream of the cDNA start codon, a missense mutation which leads to an amino acid substitution Asp299Gly in the third exon of the TLR4 gene, and which was later shown to co-segregate with SNP Thr399Ile-also in the third exon of TLR4.1 This SNP, present in 10% of the general population, has been found associated with gastric cancer, prostate cancer, and nasopharyngeal cancer.2-4 Pre-clinical studies from our laboratory have shown an association of TLR4 with ultraviolet radiation induced skin cancer. Hence, in this study we will assess the pattern of TLR4 polymorphisms and susceptibility to skin cancer.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Asp299Gly SNP in the third exon of the TLR4 gene will be detected in blood
Time frame: once during the course of study
TLR4 SNP Asp299Gly
University of Alabama at Birmingham
Other
TLR4 Polymorphisms and Predisposition for Skin Cancer Development
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01535963
Neoplasms, Neoplasms by Site
Chicago, Illinois, United States
View Trial DetailsNCT07670403
Basal Cell Carcinoma of Skin, Behavior
Chengdu, Sichuan, China
View Trial DetailsNCT05313711
Neoplasms, Neoplasms by Site
Aberdeen, United Kingdom
View Trial DetailsNCT05774600
Neoplasms, Neoplasms by Site
Golden, Colorado, United States
View Trial Details